Pfizer’s Lipitor Gains Stroke, Heart Attack Indication In Diabetic Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Atorvastatin’s expanded label also includes an indication for reducing the risk of stroke in patients without evidence of heart disease but with multiple risk factors other than diabetes.
You may also be interested in...
Pfizer Turns To Lipitor DTC To Pump Up Lipid-Lowering Market
Pfizer hopes new branded and unbranded ads will reinvigorate the cholesterol-lowering category following flat third-quarter sales for the statin in the U.S.
Pfizer Turns To Lipitor DTC To Pump Up Lipid-Lowering Market
Pfizer hopes new branded and unbranded ads will reinvigorate the cholesterol-lowering category following flat third-quarter sales for the statin in the U.S.
Lipitor Class Action Suit Alleges Improper Promotion To Women And Elderly
Complaint cites Pfizer's promotion to physicians, direct-to-consumer advertising and public relations campaigns.